Liquid Biopsy Better Option for Advanc... - Lung Cancer Support

Lung Cancer Support

4,050 members2,201 posts

Liquid Biopsy Better Option for Advanced Lung Cancer Patients

FtB_Travis profile image
2 Replies

Imagine, getting a simple, noninvasive blood test instead of a surgical procedure to test for advanced lung cancer mutations. Then, imagine the liquid biopsy being the more efficient and reliable option of the two.

Research is even showing that liquid biopsies are capturing clinically relevant mutations not found in tissue biopsies.

What do you think of this new biopsy option? Do you think it will improve the quality of life for lung cancer patients?

Full article: genengnews.com/gen-news-hig...

Written by
FtB_Travis profile image
FtB_Travis
To view profiles and participate in discussions please or .
Read more about...
2 Replies
Heather1959 profile image
Heather1959

Absolutely, but it would be even better if a liquid biopsy could be done as part of a yearly check up to diagnose cancer in it's early stages. This would also lead to personalized treatments and would be much less costly compared to late stage treatments and CT scans.

This liquid biopsy is on my oncologist's list of future "to do" items if and when my stage iv tumors grow but if your cancer burden is not big enough, the biopsy will read negative if there isn't e ouch cancer byproduct in te urine. A terrific tool but not a true replacement for more invasive tissue testing. He believes I could be one of many whose initial testing produces a negative results for certain genetic markers that can be later discovered through this test.

Not what you're looking for?

You may also like...

FDA approves another blood test for a mutation (T790M) in lung cancer

Some of you may have heard about new blood tests to check for lung cancer mutations. And you may...

Liquid Biopsies Are Important in Lung Cancer, Expert Says

Liquid biopsies may be a quick and less intrusive way of detecting non-small cell lung cancer....

Opdivo and Yervoy combination approved for Non-small cell lung cancer

More exciting approval announcements for this week. On May 15th, 2020, the Food and Drug...

Lung cancer? Me? No way.......

A few months ago if you would have asked me to list 10 things from which I might die, I would have...

First Targeted Adjuvant Therapy for EGFR Non Small Cell Lung Cancer (stage IB-IIIA)

On December 18th, 2020, the Food and Drug Administration (FDA) approved Tagrisso (osimertinib) for...